Cemiplimab + Chemo vs Cemiplimab + Chemo + other treatments in patients with resectable NSCLC

A randomized phase 2 platform study to evaluate cemiplimab plus chemotherapy versus cemiplimab plus chemotherapy plus other cancer treatments for the perioperative treatment of patients with resectable non-small cell lung cancer (R2810-ONC-2268)

Disease Types: Lung

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A randomized phase 2 platform study to evaluate cemiplimab plus chemotherapy versus cemiplimab plus chemotherapy plus other cancer treatments for the perioperative treatment of patients with resectable non-small cell lung cancer (R2810-ONC-2268)

For More Information:

https://clinicaltrials.gov/study/NCT06465329?term=(R2810-ONC-2268)&rank=1